CoRiCal: COVID-19 Risk Calculator

CoRiCal is a tool to help people make decisions about getting a COVID-19 vaccine. It shows how the vaccine can lower the chance of catching, getting sick from or dying from COVID-19. It also shows the chance of getting rare side effects from the vaccines.

The tool shows the chance based on your age, sex, and vaccinations. You can choose to see the results ‘as a chance' or 'per million people' by clicking on the tabs.

The results shown are only a guide. The tool shows the average result for people with the same sex and age as you. This tool does not consider other things that can change your chance of infection or illness from COVID-19. This includes your general health, where you work or go to school, or your COVID-19 safe behaviours.

When making decisions about getting a COVID-19 vaccine, you should also consider how your chance might change in the future. This might include a change in the number of cases in your community or travel to an area with more cases.

Watch these videos for examples of how to understand the risk calculator results: general model, kids model, long covid model.

Back to calculator

Long Covid Podcast Series

Rationale

Five percent of people who get COVID will develop long COVID. Between 500,000 and 1 million people have had (or still have long COVID). The median duration is 4 months and while there are no definitive treatment(s), a rehabilitation approach has proven to be effective. It has been estimated the $9.6 billion (0.5% of GDP) has been lost in people with long COVID being unable to return to work for many months. The GP is in the frontline for managing long COVID and many GPs are unclear about their role or how they can more effectively help their patients with long COVID.

Being up to date with COVID vaccine boosters and early intervention with anti-virals (Paxlovid) (or possibly metformin) if a person gets COVID, can reduce the incidence of long COVID.

The main target audience for these podcasts is GPs and consumers

Three of the podcasts have been recorded: two with Professor Steven Faux AM (previous GP and now head of rehabilitation at St Vincent’s hospital, Sydney) and one with Professor Brendan Crabb AC (CEO of the Burnett Institute, Melbourne). Both speakers have established reputations in the area of long COVID.

Professor Steven Faux AM is a Rehabilitation expert. He had been a GP for a number of years. He runs the largest and longest running Long COVID clinic at St Vincents hospital in Sydney. He has authored a very good up to date summary paperback book on Long COVID in April this year. He has been a longstanding informed commentator on long COVID and is involved in a number of ongoing research projects looking into long COVID.

Professor Brendan Crabb AC is a virologist and head of the prestigious Burnet institute in Melbourne. He has also been a leading investigator into the underlying pathophysiology of long COVID and has done a lot of work looking at strategies to improve air quality and its impact on getting COVID.

Steven discusses the risk factors for long COVID, the underlying pathophysiology and symptom clusters in the first podcast and treatment and prevention in the second podcast, including getting a COVID booster. Less than 1 in 4 adults 75 years and older have had a COVID booster in the last 6 months.

Brendan discusses the current research on the underlying pathophysiology and what treatments are emerging in the research.

Name Title & ContentDuration
Professor Steven FauxLong COVID Part 1
  • Understand the definition, incidence and the symptoms of long COVID
  • Cluster symptoms to help you understand the different presentations from the patient
  • What risk factors predispose patients to long COVID
  • What investigations as a GP may help you diagnose long COVID
  • Rehabilitation of the patient is key, and it’s essential to develop tailored plans while ensuring appropriate referral pathways are in place when needed
  • How healthcare professions can assist patients to discuss with employers their rehabilitation plan and return to work
31.19 mins
Professor Steven FauxLong COVID Part 2
  • Natural history of Long COVID, although up to 95% patients will improve their symptoms; it is a long process
  • Role of vaccination in prevention of Long COVID in patients at higher risk
  • Role of Metformin in prevention of symptoms of Long COVID and how it is best used in clinics
  • Type of rehabilitation patients with Long COVID need
  • Impact on interpersonal relationships and the role of family and community
  • General practitioners and allied health can together make a significant improvement to patient outcomes
41 mins
Professor Brendan CrabbLong COVID: Current research on risk factors, pathophysiology, and emerging treatments
  • Why long COVID is a large and growing concern as new insights emerge at great speed
  • Understand the proposed mechanisms driving long COVID, including the two main mechanisms of persistent infection and the role of toxic fibrin induced vascular damage
  • Role of antivirals in reducing the duration, severity and potentially preventing the impact of long COVID
  • Three hierarchical drivers of preventing the impact of long COVID, how can this messaging help your patient
  • What should be your tool kit of prevention, when explaining long COVID to your patients
  • Risk of long lasting viraemia in the body causing future chronic conditions
50 mins
Associate Professor John LittLong COVID: Current research on risk factors, pathophysiology, and emerging treatments
  • Use of CoRiCal, a COVID risk calculator (including long COVID); beneficial as a tool in your practice
  • Long COVID version of CoRiCal. Estimating an individual’s risk of long COVID based upon age, sex, comorbidities, number of COVID episodes, number of COVID vaccines, date of last COVID booster
4 mins

You can find the Long Covid Podcast Series at this link.

Video Overview

The CoRiCal team have produced a few short film clips to outline:

  • what is CoRiCal, our COVID-19 Risk calculator, and who has contributed to its construction
  • why it was developed,
  • why it is both useful and unique, summarising the strengths of using such a decision-making tool.
  • the risk chart for COVID-19 deaths to estimate the likely risk of dying from COVID-19 based upon age, sex and number of COVID-19 vaccine doses.
  • an example using the CoRiCal tool to explain the risk and benefit of COVID-19 vaccination for children.
There are 5 very brief clips, each about 1 ½ minutes in length. There is one longer film clip (~7 ½ minutes) that puts all these sections together. GPs and health care professionals offering COVID-19 vaccines are welcome to download the film clips to their desktop or even consider installing them on the TV in the patient waiting room.

Using the CoRiCal tool for a personalised COVID-19 vaccine risk assessment - Long COVID


Explanation of the CoRiCal Kids Model


General Model


Full CoRiCal Video


What is CoRiCal?


Why did the academic team develop CoRiCal?

A significant number of people ( ~30%) have not had a COVID-19 vaccine booster. This puts them at considerable risk from the more recent Omicron COVID-19 variants as they have little protection. Given that nearly 75% of the deaths from COVID-19 have occurred this year and can be attributed to Omicron.


Strengths of CoRiCal


Risk of dying from COVID-19



Acknowledgements

The CoRiCal team are very grateful to Dr Ramesh Manocha and his team HealthEd for graciously providing their film crew to film the CoRiCal clips at no cost. The CoRiCal team are also grateful to Kim Sampson, Jayne Geddes and the team at the Immunisation Coalition in providing ongoing administrative support to the development of CoRiCal.

CoRiCal co-chairs: Colleen Lau, John Litt, Kirsty Short
Project conception: Andrew Baird, John Litt, Kirsty Short
Web Development: Aapeli Vuorinen, Tina Moghaddam, Hongen Lu
Subject expertise: Andrew Baird, Anoop Enjeti, Colleen Lau, John Litt, Raj Puranik, Kirsty Short, Tej Shukla, Sudhir Wahi, Olivia Williams, Sophie Wen, Phil Britton
Model design: Colleen Lau, Helen Mayfield, Kerrie Mengersen, Tej Shukla, Jane Sinclair, Ramona Muttucumaru, Sam Brown, Olivia Williams
Data acquisition: Andrew Baird, Anoop Enjeti, Colleen Lau, John Litt, Tej Shukla, Kirsty Short
Data analysis: Samuel Brown, Colleen Lau, Helen Mayfield, Kerrie Mengersen, Jane Sinclair, Michael Waller
Risk Communication: Carissa Bonner (videos), Colleen Lau, John Litt, Kirsty Short, Jane Sinclair
Administration and project management: Jayne Geddes, John Litt, Helen Mayfield, Kim Sampson, Kirsty Short, Hongen Lu

Collaborating institutions
University of Queensland
Flinders University
Queensland University of Technology
University of Sydney
BayesFusion
© 2021-2023 Immunisation Coalition.